Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

NCT00594698 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: PB127 for injectable suspension

Sponsor

Point Biomedical